logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12296085 B1

PDFFull Text
Date of Patent:
May. 13, 2025

Filed:

Mar. 31, 2017

Method for extracorporeal treatment of preeclampsia and related disorders

Applicant:

Immutrix Therapeutics, Inc., Rapid City, SD (US);

Inventors:

Carol A. Rae, Rapid City, SD (US);

Jan Simoni, Rapid City, SD (US);

John F. Moeller, Rapid City, SD (US);

Assignee:

Immutrix Therapeutics, Inc., Rapid City, SD (US);

Attorneys:

Barnes & Thornburg LLP

Jerry C. Harris, Jr.

Primary Examiner:

Christina M Borgeest

Int. Cl.
CPC ...
A61M 1/36 (2006.01); A61K 33/44 (2006.01); A61M 1/34 (2006.01); B01D 15/00 (2006.01); B01J 20/20 (2006.01); B01J 20/26 (2006.01); B01J 20/28 (2006.01); B01J 20/32 (2006.01);
U.S. Cl.
CPC ...
A61M 1/3679 (2013.01); A61K 33/44 (2013.01); A61M 1/3486 (2014.02); B01D 15/00 (2013.01); B01J 20/20 (2013.01); B01J 20/265 (2013.01); B01J 20/28016 (2013.01); B01J 20/28052 (2013.01); B01J 20/28092 (2013.01); B01J 20/3204 (2013.01); B01J 20/321 (2013.01); B01J 20/3212 (2013.01); B01J 20/3242 (2013.01); B01J 20/3293 (2013.01);
Abstract

A three-component composition for use in the treatment of preeclampsia and related disorders wherein a first component comprises a bimodal synthetic carbon particle mixture; a second component comprises a resin bead with at least one affinity ligand directed toward syncytiotrophoblast-derived factor sEndoglin and a third component comprises a resin bead with at least one affinity ligand directed toward syncytiotrophoblast-derived factor soluble Fms-like tyrosine kinase-1.

Find Patent Forward Citations

Rae, Carol. (2025). Method for extracorporeal treatment of preeclampsia and related disorders (U.S. Patent No. 12296085). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12296085

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…